RSI Warning: Stevanato Group SpA (STVN) is Currently Oversold
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 14 2025
0mins
Source: NASDAQ.COM
Stevanato Group's Stock Performance: Shares of Stevanato Group SpA (STVN) reached an oversold territory with an RSI of 28.2, trading as low as $22.01 per share, compared to the S&P 500 ETF's RSI of 47.0.
Potential Buying Opportunity: The low RSI reading may indicate that the heavy selling is nearing exhaustion, suggesting potential entry points for bullish investors.
52-Week Range: STVN's stock has a 52-week low of $17.49 and a high of $28, with the last trade recorded at $22.08.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy STVN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on STVN
Wall Street analysts forecast STVN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STVN is 27.00 USD with a low forecast of 24.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 16.000
Low
24.00
Averages
27.00
High
30.00
Current: 16.000
Low
24.00
Averages
27.00
High
30.00
About STVN
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
S&P 500 Index Edges Up as Tech Stocks Rally
- Tech Stock Rally: The S&P 500 Index rose by 0.03% driven by a rebound in the Magnificent Seven tech stocks, indicating a recovery in market confidence despite ongoing uncertainties.
- Consumer Confidence Boost: The University of Michigan's consumer sentiment index was revised up to 56.4, a five-month high, exceeding expectations of 54.0, suggesting increased consumer confidence that could stimulate spending.
- Easing Inflation Expectations: The one-year inflation expectations were revised down from 4.2% to 4.0%, reflecting a reduction in market concerns about future inflation, which may support stock performance.
- Oil Price Surge: WTI crude oil prices jumped over 2% to a one-week high as President Trump reiterated military threats against Iran, boosting energy stocks and highlighting the impact of geopolitical risks on the market.

Continue Reading
S&P 500 Futures Rise in Pre-Market Session; Venture Global and Karman Holdings Take the Lead
- Market Opening: U.S. stock markets are set to open in two hours.
- Venture Global Inc. Performance: Venture Global Inc. (VG) saw a 9.9% increase in pre-market trading.
- Karman Holdings Inc. Performance: Karman Holdings Inc. (KRMN) experienced a 9.5% rise in pre-market trading.
- Overall Market Sentiment: The pre-market gains indicate positive sentiment ahead of the market opening.

Continue Reading





